{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T03:18:20Z","timestamp":1791429500701,"version":"4.3.3"},"reference-count":18,"publisher":"Elsevier BV","issue":"37","license":[{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,8,2]],"date-time":"2021-08-02T00:00:00Z","timestamp":1627862400000},"content-version":"am","delay-in-days":366,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100009947","name":"Merck Sharp and Dohme","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009947","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2020,8]]},"DOI":"10.1016\/j.vaccine.2020.07.004","type":"journal-article","created":{"date-parts":[[2020,7,21]],"date-time":"2020-07-21T03:26:17Z","timestamp":1595301977000},"page":"5891-5895","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":22,"title":["Acceptability and perception of the herpes zoster vaccine in the 65 and over population: A French observational study"],"prefix":"10.1016","volume":"38","author":[{"given":"Corinne","family":"Del Signore","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anaelle","family":"Hemmendinger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nagham","family":"Khanafer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacques","family":"Thierry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisabeth","family":"Tr\u00e9po","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G\u00e9raldine","family":"Martin Gaujard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roland","family":"Chapurlat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christelle","family":"Elias","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe","family":"Vanhems","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2020.07.004_b0005","first-page":"1512","article-title":"Risque des \u00e9pid\u00e9mies contagieuses dans les structures g\u00e9riatriques","volume":"31","author":"Trivalle","year":"2002","journal-title":"Presse Med"},{"key":"10.1016\/j.vaccine.2020.07.004_b0010","unstructured":"GEIG (Groupe d\u2019Expertise et d\u2019Information sur la Grippe), http:\/\/www.grippe-geig.com\/access february 2020."},{"key":"10.1016\/j.vaccine.2020.07.004_b0015","first-page":"21","article-title":"Immunization schedule in the elderly","volume":"13","author":"Gavazzi","year":"2015","journal-title":"Geriatr Psychol Neuropsychiatr Vieil"},{"key":"10.1016\/j.vaccine.2020.07.004_b0020","unstructured":"Haut Conseil de la Sant\u00e9 Publique (HCSP). Le calendrier des vaccinations et les recommandations vaccinales 2018. http:\/\/solidarites-sante.gouv.fr\/prevention-en-sante\/preserver-sa-sante\/calendrier-vaccinal\/access february 2020."},{"key":"10.1016\/j.vaccine.2020.07.004_b0025","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1007\/BF03324909","article-title":"Herpes zoster and postherpetic neuralgia: a review of the effects of vaccination","volume":"21","author":"Johnson","year":"2009","journal-title":"Aging Clin Exp Res"},{"key":"10.1016\/j.vaccine.2020.07.004_b0030","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1056\/NEJMct066061","article-title":"Varicella-Zoster vaccine for the prevention of herpes zoster","volume":"356","author":"Kimberlin","year":"2007","journal-title":"N Engl J Med"},{"issue":"7264","key":"10.1016\/j.vaccine.2020.07.004_b0035","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1136\/bmj.321.7264.794","article-title":"Prevalence of postherpetic neuralgia after a first episode of herpes zoster: prospective study with long term follow up","volume":"321","author":"Helgason","year":"2000","journal-title":"BMJ"},{"key":"10.1016\/j.vaccine.2020.07.004_b0040","unstructured":"Mirinaviciute G, Quist-Paulsen E, Brants\u00e6ter AB, Flem E. The burden of herpes zoster disease in Norway. Vaccine 2019;pii: S0264-410X(19)31596-8."},{"key":"10.1016\/j.vaccine.2020.07.004_b0045","unstructured":"Avis de transparence HAS 2014, https:\/\/www.mesvaccins.net\/textes\/CT-3478_ ZOSTAVAX _ PIC_Ins_Avis3_C \/ (access January 2020)."},{"key":"10.1016\/j.vaccine.2020.07.004_b0050","doi-asserted-by":"crossref","first-page":"2271","DOI":"10.1056\/NEJMoa051016","article-title":"Vaccine to prevent herpes zoster and post herpetic neuralgia in older adults","volume":"252","author":"Oxman","year":"2005","journal-title":"N Engl J Med"},{"issue":"17","key":"10.1016\/j.vaccine.2020.07.004_b0055","doi-asserted-by":"crossref","first-page":"2371","DOI":"10.1016\/j.vaccine.2018.02.021","article-title":"Effectiveness of herpes zoster vaccination in an older United Kingdom population","volume":"36","author":"Walker","year":"2018","journal-title":"Vaccine"},{"issue":"2","key":"10.1016\/j.vaccine.2020.07.004_b0060","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0229224","article-title":"Burden of disease from shingles and post-herpetic neuralgia in the over 80 year olds in the UK","volume":"15","author":"Matthews","year":"2020","journal-title":"PLoS One"},{"key":"10.1016\/j.vaccine.2020.07.004_b0065","unstructured":"http:\/\/www.cpias-auvergnerhonealpes.fr\/animation\/ehpad_fam_mas_ime\/2019\/20_06_19\/2 _ vaccination_sujets_ages.pdf."},{"issue":"10","key":"10.1016\/j.vaccine.2020.07.004_b0070","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2016-011539","article-title":"Evaluation of the acceptability of a vaccine against herpes zoster in the over 50 years old: an Italian observational study","volume":"6","author":"Valente","year":"2016","journal-title":"BMJ Open"},{"issue":"3","key":"10.1016\/j.vaccine.2020.07.004_b0075","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1086\/421942","article-title":"Acute pain in herpes zoster and its impact on health-related quality of life","volume":"39","author":"Katz","year":"2004","journal-title":"Clin Infect Dis"},{"issue":"6","key":"10.1016\/j.vaccine.2020.07.004_b0080","doi-asserted-by":"crossref","first-page":"3019","DOI":"10.1111\/hex.12286","article-title":"Using the Health Belief Model to explain patient involvement in patient safety","volume":"18","author":"Bishop","year":"2015","journal-title":"Health Expect"},{"key":"10.1016\/j.vaccine.2020.07.004_b0085","doi-asserted-by":"crossref","first-page":"10798","DOI":"10.1016\/j.diabres.2019.107983","article-title":"Diabetes as a risk factor for herpes zoster in adults: a synthetic literature review","volume":"159","author":"Saadatian-Elahi","year":"2020","journal-title":"Diabetes Res Clin Pract"},{"issue":"4","key":"10.1016\/j.vaccine.2020.07.004_b0090","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1097\/ICU.0000000000000491","article-title":"Herpes zoster ophthalmicus: acute keratitis","volume":"29","author":"Jy","year":"2018","journal-title":"Curr Opin Ophthalmol"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X2030904X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X2030904X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T10:45:32Z","timestamp":1759401932000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X2030904X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8]]},"references-count":18,"journal-issue":{"issue":"37","published-print":{"date-parts":[[2020,8]]}},"alternative-id":["S0264410X2030904X"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2020.07.004","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2020,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Acceptability and perception of the herpes zoster vaccine in the 65 and over population: A French observational study","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2020.07.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}